Additionally, multi-omics approaches combining weighted gene co-expression networks (WGCNA) with experimental validation identified biomarkers like ALOX5 (associated with invasion) and ADH1A (linked to chemosensitivity) in pancreatic cancer. This evidence concerns the gene ALOX5 and familial pancreatic carcinoma.